Novartis (NYSE:NVS) Coverage Initiated at The Goldman Sachs Group
The Goldman Sachs Group began coverage on shares of Novartis (NYSE:NVS – Free Report) in a report issued on Thursday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $120.00 target price on the stock. Separately, BMO Capital Markets lifted their target price on Novartis from $114.00 to $116.00 and gave the company […]
More Stories
Brokerages Set Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Price Target at $60.56
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty ratings...
Lennar Co. (LEN) to Issue Quarterly Dividend of $0.50 on October 24th
Lennar Co. (NYSE:LEN – Get Free Report) announced a quarterly dividend on Wednesday, September 25th, NASDAQ reports. Shareholders of record...
Industria de Diseño Textil, S.A. (OTCMKTS:IDEXY) Plans Dividend of $0.29
Industria de Diseño Textil, S.A. (OTCMKTS:IDEXY – Get Free Report) announced a dividend on Saturday, October 5th, NASDAQ reports. Investors...
Freehold Royalties Ltd. (TSE:FRU) Given Average Rating of “Moderate Buy” by Analysts
Freehold Royalties Ltd. (TSE:FRU – Get Free Report) has received a consensus rating of “Moderate Buy” from the eight research...
Apogee Enterprises (NASDAQ:APOG) Updates FY 2025 Earnings Guidance
Apogee Enterprises (NASDAQ:APOG – Get Free Report) issued an update on its FY 2025 earnings guidance on Friday morning. The...
NAOS Emerging Opportunities Company Limited (ASX:NCC) Plans Final Dividend of $0.02
NAOS Emerging Opportunities Company Limited (ASX:NCC – Get Free Report) declared a final dividend on Thursday, October 3rd, MarketIndexAU reports....